Presence Study

Health & Fitness

Free

PRESENCE is a research study app exclusively for enrolled participants in the PRESENCE clinical trial, which examines pain management approaches for individuals with sickle cell disease (SCD). This app is not available for public download or use. Key Features (for enrolled participants only): • Daily pain and mood tracking • Educational modules about pain management • Secure messaging with study staff • Study questionnaire completion • Progress tracking and reporting IMPORTANT: This app requires a study-specific enrollment ID and can only be used by individuals who are officially enrolled in the PRESENCE clinical trial. If you are interested in participating in the study, please contact your healthcare provider or visit [study website URL] for more information. Privacy & Security: • HIPAA-compliant • Encrypted data transmission • Secure authentication required • IRB-approved research protocols Device Requirements: • Requires iOS 15.0 or later • Compatible with iPhone and iPod touch Category: Medical Age Rating: 12+ Note: Limited distribution app - for enrolled study participants only

  • This app hasn’t received enough ratings or reviews to display an overview.

- Internal fixes for Carisma chat bot

The developer, RC21X, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Contact Info

Privacy practices may vary, for example, based on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

Seller
HOME BASE IMPAIRMENT COMPANY, INC.
Size
1.5 GB
Category
Health & Fitness
Compatibility
Requires iOS 15.0 or later.
  • iPhone
    Requires iOS 15.0 or later.
  • iPad
    Requires iPadOS 15.0 or later.
  • iPod touch
    Requires iOS 15.0 or later.
Languages
English
Age Rating
9+
Copyright
© RC21X, 2025